bioMerieux (BMXMF)
(Delayed Data from OTC)
$106.45 USD
0.00 (0.00%)
Updated May 8, 2024 10:56 AM ET
4-Sell of 5 4
C Value B Growth F Momentum C VGM
Industry / Sector Report
Industry : Medical Services
Zacks Industry Rank
Top 35% (87 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.67 | 1.51 | 9.99 |
Current Quarter Estimate | NA | -0.48 | 57.00 |
Year Ago Quarter Estimate | NA | 0.07 | 52.54 |
Next Quarter Estimate | NA | 1.48 | 61.00 |
Next Year Estimate | 5.03 | 8.09 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 35.89 | 11.80 | 15.67 |
Next Year | 13.54 | 23.40 | 9.31 |
Last 5 Years | 5.70 | 9.50 | 8.10 |
Next 5 Years | NA | 14.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 17.34 |
Price/Book (MRQ) | 3.17 | 2.03 |
Price/Cash Flow (MRFY) | 18.05 | 13.41 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | 3.19% |
Return on Equity (TTM) | NA | 6.91% |
Debt to Equity (MRQ) | NA | 40.29 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.